Development of a Recombinant Antibody-Based Treatment of Snakebites

Mikael Engmark; Andreas Hougaard Laustsen; Mikael Rørdam Andersen; Susanne Jacobsen; Federico De Masi; Ole Lund

Development of a Recombinant Antibody-Based Treatment of Snakebites

Mikael Engmark, Andreas Hougaard Laustsen, Mikael Rørdam Andersen, Susanne Jacobsen, Federico De Masi, Ole Lund

University of Copenhagen

Research output: Contribution to conference › Poster › Research › peer-review

216 Downloads (Pure)

Abstract

Antivenom for snakebites is produced by immunization of large mammals with snake venom using atraditional and expensive method developed in the 1890’s. Due to the animal origin, the products arehighly immunogenic and come with a high risk of adverse side effects such as serum sickness andanaphylaxis, possibly leading to death.

Original language	English
Publication date	2014
Number of pages	1
Publication status	Published - 2014
Event	11th Protein.DTU Workshop - , Denmark Duration: 12 May 2014 → …

Workshop

Workshop	11th Protein.DTU Workshop
Country/Territory	Denmark
Period	12/05/2014 → …

Access to Document

Development of a Recombinant Antibody Based Treatment of SnakebitesFinal published version, 2.95 MB

OpenUrl availability

Full text

Cite this

@conference{793099225d364573b1b7221b252fc4fc,

title = "Development of a Recombinant Antibody-Based Treatment of Snakebites",

abstract = "Antivenom for snakebites is produced by immunization of large mammals with snake venom using atraditional and expensive method developed in the 1890{\textquoteright}s. Due to the animal origin, the products arehighly immunogenic and come with a high risk of adverse side effects such as serum sickness andanaphylaxis, possibly leading to death.",

author = "Mikael Engmark and Laustsen, {Andreas Hougaard} and Andersen, {Mikael R{\o}rdam} and Susanne Jacobsen and {De Masi}, Federico and Ole Lund",

year = "2014",

language = "English",

note = "11th Protein.DTU Workshop ; Conference date: 12-05-2014",

}

TY - CONF

T1 - Development of a Recombinant Antibody-Based Treatment of Snakebites

AU - Engmark, Mikael

AU - Laustsen, Andreas Hougaard

AU - Andersen, Mikael Rørdam

AU - Jacobsen, Susanne

AU - De Masi, Federico

AU - Lund, Ole

PY - 2014

Y1 - 2014

N2 - Antivenom for snakebites is produced by immunization of large mammals with snake venom using atraditional and expensive method developed in the 1890’s. Due to the animal origin, the products arehighly immunogenic and come with a high risk of adverse side effects such as serum sickness andanaphylaxis, possibly leading to death.

AB - Antivenom for snakebites is produced by immunization of large mammals with snake venom using atraditional and expensive method developed in the 1890’s. Due to the animal origin, the products arehighly immunogenic and come with a high risk of adverse side effects such as serum sickness andanaphylaxis, possibly leading to death.

M3 - Poster

T2 - 11th Protein.DTU Workshop

Y2 - 12 May 2014

ER -

Development of a Recombinant Antibody-Based Treatment of Snakebites

Abstract

Workshop

Access to Document

OpenUrl availability

Fingerprint

Cite this